Effect of clinical signs, endocrinopathies, timing of surgery, hyperlipidemia, and hyperbilirubinemia on outcome in dogs with gallbladder mucocele.
JA Jaffey,
M Pavlick,
CR Webster,
GE Moore,
KA McDaniel,
SL Blois,
EM Brand,
CF Reich,
L Motschenbacher,
ET Hostnik,
D Su,
JA Lidbury,
O Raab,
SV Carr,
KE Mabry,
W Fox-Alvarez,
S Townsend,
S Palermo,
Y Nakazono,
K Ohno,
E VanEerde,
H Fieten,
AH Hulsman,
K Cooley-Lock,
M Dunning,
C Kisielewicz,
A Zoia,
M Caldin,
A Conti-Patara,
L Ross,
C Mansfield,
O Lynn,
MA Claus,
PJ Watson,
A Swallow,
DA Yool,
K Gommeren,
M Knops,
V Ceplecha,
H de Rooster,
R Lobetti,
O Dossin,
F Jolivet,
LG Papazoglou,
MCF Pappalardo,
F Manczur,
Z Dudás-Györki,
EJ O'Neill,
C Martinez,
A Gal,
RL Owen,
E Gunn,
K Brown,
LK Harder,
C Griebsch,
KP Anfinsen,
TK Gron,
V Marchetti,
RM Heilmann,
P Pazzi,
AE DeClue
Oct 21, 2019
Gallbladder mucocele (GBM) is a common extra-hepatic biliary syndrome in dogs with death rates ranging from 7 to 45%. Therefore, the aim of this study was to identify the association of survival with variables that could be...